Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2024BMC AnesthesiologyOpen Access

Effect of esketamine on serum neurotransmitters in patients with postpartum depression: a randomized controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

QJQinyu JiangYQYu QiMZMeiyan Zhou

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jiang et al. (2024) studied this question.

synapsesocial.com/papers/68e5bb2db6db643587553427https://doi.org/10.1186/s12871-024-02681-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploring Esketamine’s Therapeutic Role for Perinatal Depression via TASK-1 Tandem Pore Potassium Channels2025
  2. 2Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial2024 · 69 citations
  3. 3Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial2026
  4. 4Low dose of esketamine after childbirth helps mothers at risk of depression2024
  5. 5Peripartum administration of esketamine: a way to prevent postpartum depression?2025